Utama › Krisis Oklusif Vaskular › Maryland

Kajian klinikal Krisis Oklusif Vaskular di Maryland

3 kajian untuk Krisis Oklusif Vaskular sedang mencari peserta di lokasi di Maryland.

Teks kajian rasmi (Bahasa Inggeris)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

The Johns Hopkins University School of Medicine, Baltimore

Mengambil pesertaFasa 3

Umur 12 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06439082

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

University of Maryland, Baltimore

Mengambil pesertaFasa 2

Umur 12 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Center for Cancer and Blood Disorders, Bethesda

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07224360

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.